scholarly journals Future development of gastrointestinal cancer incidence and mortality rates in Switzerland: a tumour registry- and population-based projection up to 2030

2015 ◽  
Author(s):  
GR Joliat ◽  
D Hahnloser ◽  
N Demartines ◽  
M Schäfer
Keyword(s):  
Cancer Incidence ◽  
Future Development ◽  
Gastrointestinal Cancer ◽  
Mortality Rates ◽  
Population Based ◽  
Incidence And Mortality

scholarly journals Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: a multicentre population-based cohort study

Gut ◽  
2020 ◽  
pp. gutjnl-2019-320200 ◽  
Author(s):  
Ru Chen ◽  
Yong Liu ◽  
Guohui Song ◽  
Bianyun Li ◽  
Deli Zhao ◽  
...  
Keyword(s):  
Cohort Study ◽  
Cancer Incidence ◽  
Gastrointestinal Cancer ◽  
Screening Programme ◽  
Population Based ◽  
Control Group ◽  
Endoscopic Screening ◽  
Upper Gastrointestinal Cancer ◽  
Incidence And Mortality ◽  
Upper Gastrointestinal

ObjectivesTo estimate the effectiveness of endoscopic screening programme in reducing incidence and mortality of upper gastrointestinal cancer in high risks areas of China.DesignThis multicentre population-based cohort study was conducted in six areas in China from 2005 to 2015. All permanent residents aged 40 to 69 years were identified as target subjects. We refer to those who were invited for screening collectively as the invited group. Of these, we classify those who were invited and undertook endoscopic screening as the screened group and those who were invited but did not accept screening as the non-screened group. Target subjects who were not invited to the screening were assigned to the control group. The effectiveness of the endoscopic screening and screening programme were evaluated by comparing reductions in incidence and mortality from upper gastrointestinal cancer in the screened and invited group with control group.ResultsOur cohort analysis included 637 500 people: 299 483 in the control group and 338 017 in the invited to screening group, 113 340 (33.53%) of whom were screened eventually. Compared with subjects in the control group, upper gastrointestinal cancer incidence and mortality decreased by 23% (relative risk (RR)=0.77, 95% CI 0.74 to 0.81) and 57% (RR=0.43, 95% CI 0.40 to 0.47) in the screened group, respectively, and by 14% (RR=0.86, 95% CI 0.84 to 0.89) and 31% (RR=0.69, 95% CI 0.66 to 0.72) in the invited group, respectively.ConclusionAmong individuals aged 40 to 69 years in high risk areas of upper gastrointestinal cancer, one-time endoscopic screening programme was associated with a significant decrease in upper gastrointestinal cancer incidence and mortality.

scholarly journals Cancer incidence and mortality in the Bucaramanga metropolitan area, 2003-2007

2012 ◽  
pp. 290-297 ◽  
Author(s):  
Claudia Janeth Uribe ◽  
Sonia Osma ◽  
Victor Herrera
Keyword(s):  
Metropolitan Area ◽  
Cancer Incidence ◽  
Cancer Registries ◽  
Mortality Rates ◽  
Population Based ◽  
World Population ◽  
Worldwide Population ◽  
Limited Effectiveness ◽  
Incidence And Mortality ◽  
Incident Cases

Introduction: Cancer is an important cause of morbidity and mortality worldwide. Population-based cancer registries (PB­CRs) make possible to estimate the burden of this condition. Objetive: To estimate cancer incidence and mortality rates in the Bucaramanga Metropolitan Area (BMA) during 2003-2007. Methods: Incident cases of invasive cancer diagnosed during 2003-2007 were identified from the Bucaramanga Metropolitan Area PBCR (BMA-PBCR). Population counts and mortality were obtained from the Colombian National Administrative De­partment of Statistics (NADS). We estimated total and cancer-specific crude incidence and mortality rates by age group and sex, as well as age-standardized (Segi’s world population) incidence (ASIR[W]) and mortality (ASMR[W]) rates. Statistical analyses were conducted using CanReg4 and Stata/IC 10.1. Results: We identified 8,225 new cases of cancer excluding non-melanoma skin cancer (54.3% among women). Of all cases, 6,943 (84.4%) were verified by microscopy and 669 (8.1%) were detected only by death certificate. ASIR(W) for all invasive cancers was 162.8 per 100,000 women and 177.6 per 100,000 men. Breast, cervix, colorectal, stomach and thyroid were the most common types of cancer in women. In men, the corresponding malignancies were prostate, stomach, colorectal, lung and lymphoma. ASMR(W) was 84.5 per 100,000 person-years in women and 106.2 per 100,000 person-years in men. Breast and stomach cancer ranked first as causes of death in those groups, respectively. Conclusion: Overall, mortality rates in our region are higher than national estimates possibly due to limited effectiveness of secondary prevention strategies. Our work emphasizes the importance of maintaining high-quality, nationwide PBCRs.

Cancer incidence and mortality rates in multiple sclerosis: A matched cohort study

Neurology ◽  
2020 ◽  
pp. 10.1212/WNL.0000000000011219
Author(s):  
Ruth Ann Marrie ◽  
Colleen Maxwell ◽  
Alyson Mahar ◽  
Okechukwu Ekuma ◽  
Chad McClintock ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Bladder Cancer ◽  
Cohort Study ◽  
Cancer Risk ◽  
Cancer Incidence ◽  
Mortality Rates ◽  
Population Based ◽  
Colorectal Cancers ◽  
Matched Cohort ◽  
Incidence And Mortality

Objective:To determine whether cancer risk differs in people with and without multiple sclerosis (MS), we compared incidence rates and cancer-specific mortality rates in MS and matched cohorts using population-based data sources.Methods:We conducted a retrospective matched cohort study using population-based administrative data from Manitoba and Ontario, Canada. We applied a validated case definition to identify MS cases, then selected 5 controls without MS matched on birth year, sex and region. We linked these cohorts to cancer registries, and estimated incidence of breast, colorectal and 13 other cancers. For breast and colorectal cancers, we constructed Cox models adjusting for age at the index date, area-level socioeconomic status, region, birth cohort year and comorbidity. We pooled findings across provinces using meta-analysis.Results:We included 53,984 MS cases and 266,920 controls. Multivariable analyses showed no difference in breast cancer risk (pooled hazard ratio [HR] 0.92 [95%CI: 0.78-1.09]) or colorectal cancer risk (pooled HR 0.83 [95%CI: 0.64-1.07]) between the cohorts. Mortality rates for breast and colorectal did not differ between cohorts. Bladder cancer incidence and mortality rates were higher among the MS cohort. Although the incidence of prostate, uterine and central nervous system cancers differed between the MS and matched cohorts, mortality rates did not.Conclusion:The incidence of breast and colorectal cancers does not differ between persons with and without MS; however, the incidence of bladder cancer is increased. Reported differences in the incidence of some cancers in the MS population may reflect ascertainment differences rather than true differences.

scholarly journals Population-Based Study of Bloodstream Infection Incidence and Mortality Rates, Finland, 2004–2018

2021 ◽  
Vol 27 (10) ◽  
pp. 2560-2569
Author(s):  
Keiju S.K. Kontula ◽  
Kirsi Skogberg ◽  
Jukka Ollgren ◽  
Asko Järvinen ◽  
Outi Lyytikäinen
Keyword(s):  
Bloodstream Infection ◽  
Mortality Rates ◽  
Population Based ◽  
Population Based Study ◽  
Infection Incidence ◽  
Incidence And Mortality

scholarly journals Prostate Cancer Incidence and Mortality in Barbados, West Indies

2011 ◽  
Vol 2011 ◽  
pp. 1-10 ◽  
Author(s):  
Anselm J. M. Hennis ◽  
Ian R. Hambleton ◽  
Suh-Yuh Wu ◽  
Desiree H.-A. Skeete ◽  
Barbara Nemesure ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
African American ◽  
Cancer Incidence ◽  
West Indies ◽  
African American Men ◽  
Mortality Rates ◽  
Prostate Cancer Incidence ◽  
White American ◽  
Incidence And Mortality ◽  
The Us

We describe prostate cancer incidence and mortality in Barbados, West Indies. We ascertained all histologically confirmed cases of prostate cancer during the period July 2002 to December 2008 and reviewed each death registration citing prostate cancer over a 14-year period commencing January 1995. There were 1101 new cases for an incidence rate of 160.4 (95% Confidence Interval: 151.0–170.2) per 100,000 standardized to the US population. Comparable rates in African-American and White American men were 248.2 (95% CI: 246.0–250.5) and 158.0 (95% CI: 157.5–158.6) per 100,000, respectively. Prostate cancer mortality rates in Barbados ranged from 63.2 to 101.6 per 100,000, compared to 51.1 to 78.8 per 100,000 among African Americans. Prostate cancer risks are lower in Caribbean-origin populations than previously believed, while mortality rates appeared to be higher than reported in African-American men. Studies in Caribbean populations may assist understanding of disparities among African-origin populations with shared heredity.

Sign in / Sign up

Export Citation Format

Share Document